Dihydropyrimidine Dehydrogenase Is a Prognostic Marker for Mesenchymal Stem Cell-Mediated Cytosine Deaminase Gene and 5-Fluorocytosine Prodrug Therapy for the Treatment of Recurrent Gliomas
Material type:
TextPublication details: Theranostics; 2016Description: 6:10Subject(s): Online resources:
| Item type | Current library | Status | |
|---|---|---|---|
|
|
College Library | Available |
There are no comments on this title.
Log in to your account to post a comment.